Blood Journals Portfolio/X
Jul 15, 2025, 07:37
Triple Therapy Breakthrough: Corticosteroids, IVIG, and Platelet Transfusions Transform Management of Critical ITP Bleeding – Blood Journals Portfolio
The Blood Journals Portfolio reported on its official X։
“The combination of corticosteroids, IV immunoglobulin, and platelet transfusion was the most common treatment for critical ITP bleeding.”

This recent report underscores the critical role of combination therapy—corticosteroids, IV immunoglobulin, and platelet transfusion—in effectively managing severe bleeding episodes in immune thrombocytopenia (ITP). It highlights the importance of timely, comprehensive treatment approaches to significantly improve patient outcomes in life-threatening situations.
For more detailed insights on this and other hemostasis topics, visit Hemostasis Today.
American Journal of Hematology
American Society of Hematology
American Thrombosis and Hemostasis Network
ASH
Bleeding management
Blood Journals Portfolio
Corticosteroids
Critical ITP Bleeding
Emergency hematology treatment
Hemostasis therapy
Hemostasis Today
Immune thrombocytopenia
Intravenous Immunoglobulin (IVIG)
ISTH
ITP Treatment
Platelet disorders
Platelet transfusion
Triple Therapy
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis
